At least two experimental COVID-19 vaccines produced a T-cell response in participants in early-stage clinical trials, which may indicate a longer-lasting form of immunity than an antibody response. BioNTech BNTX, + 3.46% and Pfizer Inc. PFE, + 0.69% It said early Monday morning that an ongoing early-stage clinical trial for …
Read More »
British pharmacist Synairgen says she has developed a new coronavirus inhaler treatment that helps prevent hospitalized patients from becoming seriously ill. The company announced the results of a small clinical trial of its drug known as SNG001 on Monday, calling it a “breakthrough” in the fight against error, even though …
Read More »
Much of the effort to develop remedies and vaccines to combat COVID-19 has focused on the spike protein that the culprit virus, SARS-CoV-2, uses to invade healthy cells. Scientists at the Rensselaer Polytechnic Institute believe they have found a way to block the ability of the spike protein to infect …
Read More »Even the most expensive bicycle locks can be compromised in just a few minutes, and they mostly serve as deterrents, making your trip a less attractive target. But researchers at Durham University in the UK and the Fraunhofer Institute have created what they say it is first man-made material that’s …
Read More »
The coronavirus pandemic is still rapidly spreading worldwide, infecting more than 14.44 million people. With more than 188 countries and territories affected, scientists are competing to develop a vaccine against coronavirus 2 for severe acute respiratory syndrome (SARS-CoV-2), the virus that causes coronavirus disease (COVID-19). One of the forerunners in …
Read More »